Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Avasimibe and Progression of Lesions on UltraSound (A-PLUS) Investigators
Na/c25-15(7-4-3-6-13-18-12(11-34-13)22-20(29)23-18)21-9-5-1-2-8-17(27)33-24-16(26)10-14(19(24)28)35(30
Isofistularin-3 induces AHR promoter demethylation
Treatment of primary colorectal cancer xenografts with the small-molecule BMI-1 inhibitor PTC-209 resulted in colorectal CIC loss with long-term and irreversible impairment of tumor growth
Formula: C8H8Cl3NO
PR-39 - CAS# 139637-11-9 Catalog No.:M13042-10 Avasimibe and Progression of LesionsPR 39, a natural proline and arginine rich antibacterial peptide, is a noncompetitive, reversible and allosteric proteasome inhibitor. PR 39 reversibly binds to the 7 subunit of the proteasome and blocks degradation of NF B inhibitor IB by the ubiquitin proteasome pathway. PR 39 stimulates angiogenesis, inhibits inflammatory responses and significant reduces myocardial infarct size in mice. Product information CAS Number: 139637 11 9 Molecular Weight:
US$ 13.99
US$ 22.99
US$ 15.50
US$ 23.99
US$ 24.99